about
Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesisHistone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiencyValproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma CellsEpigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary diseaseFenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancerBlue journal conference. Aging and susceptibility to lung disease.Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patientsDefect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal CancerThe microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysemaMicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPDComparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells.Molecular mechanisms underlying variations in lung function: a systems genetics analysis.Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysemaSirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease.The therapeutic potential of epigenetics in autoimmune diseases.Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPDEpigenetics within the matrix: a neo-regulator of fibrotic disease.The role of hypoxia in pulmonary vascular diseases: a perspective.Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis.Pathophysiology of Emphysema and Implications.miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein.Trichostatin A resistance is facilitated by HIF-1α acetylation in HeLa human cervical cancer cells under normoxic conditions.Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.
P2860
Q24301752-28AA0BDF-A9F9-490D-9EDC-CD512E4A954DQ24619820-E6668070-D510-4BC6-A0EB-03C66A0D084DQ32177411-EB6C0D1F-0E4F-493F-B84F-E526D0E42717Q34450490-E26E9937-08E3-4FC3-BF74-1094A12E9E0AQ34551954-AE887CDE-BD27-472D-B7E5-004AFAEC77E6Q35016934-0259B73E-805F-43FD-82EF-D60D33E0CEA5Q35153456-24DABD70-8F7B-4BCD-839A-3D8CEEDCDED4Q35484702-39085C41-5450-4A5D-8958-9C50055AE17DQ35929930-EEF6B44E-B2E2-4C42-9E25-3E99DDC713DFQ35944520-7156446A-D65E-499A-AF0A-F357009E28E3Q36134550-CF1930BA-4B49-435D-8FCF-11ED6F702FECQ36212656-00338CBB-1B48-497F-A3D1-B07D6B27C6F5Q37213580-3B4C14E7-A706-4F30-937C-793E04BA54ECQ37252370-65BEE405-54B3-4055-8260-88117810E14BQ37351887-4FC18274-4814-4804-B079-FA375F149B32Q37370002-D32FFDAC-4F2B-4092-8578-FA94E58A7174Q37967566-578D63E2-D701-4512-9273-52076D4A30FEQ38030311-1AD3ECFC-47AF-4094-AEFD-3F1AECCCFC72Q38034837-C196F4F5-7D2D-4C1D-A386-BEA0E43DB4DBQ38078782-E6E2E39D-9C3C-4110-831B-B87C3128DFC0Q38213677-D5637626-E20E-431C-8E42-F693E8AD09BFQ38376048-39AAF1E1-FE00-49BB-81D4-961F0BAF383EQ38673032-DE8E842D-5CFF-457B-AEB5-99016A93ECB5Q41434213-7DD7D372-9A7D-47D7-8E73-47E692FDB1F2Q47646348-E4D5E6EB-C696-4193-93F2-6E1920363884Q49495064-D61434EF-DB7E-4DA4-B722-CD81A69701D9Q52720696-D998F3C8-76F1-415A-BB06-349E3A4171ED
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Inhibition of histone deacetylase causes emphysema.
@en
Inhibition of histone deacetylase causes emphysema.
@nl
type
label
Inhibition of histone deacetylase causes emphysema.
@en
Inhibition of histone deacetylase causes emphysema.
@nl
prefLabel
Inhibition of histone deacetylase causes emphysema.
@en
Inhibition of histone deacetylase causes emphysema.
@nl
P2093
P2860
P1476
Inhibition of histone deacetylase causes emphysema.
@en
P2093
Donatas Kraskauskas
Herman J Bogaard
Masanori Yasuo
Norbert F Voelkel
Shiro Mizuno
P2860
P304
P356
10.1152/AJPLUNG.00207.2010
P577
2010-12-17T00:00:00Z